pI: 9.1656 |
Length (AA): 569 |
MW (Da): 63763 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
35 | 65 | 1kdg (A) | 216 | 246 | 48.00 | 0 | 0.95 | 0.672982 | -0.65 |
35 | 455 | 2qa2 (A) | 2 | 375 | 20.00 | 0 | 1 | 0.806395 | 0.62 |
35 | 77 | 4i59 (A) | 31 | 68 | 61.00 | 0.014 | 0.88 | 0.650471 | -0.13 |
36 | 66 | 3k7m (X) | 2 | 32 | 45.00 | 0 | 0.78 | 0.610982 | -0.5 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_129832)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G22830 | squalene epoxidase 2 |
Arabidopsis thaliana | AT4G37760 | squalene epoxidase 3 |
Arabidopsis thaliana | AT1G58440 | probable squalene epoxidase 1 |
Candida albicans | CaO19.8036 | squalene epoxidase, erosterol biosynthesis |
Candida albicans | CaO19.406 | squalene epoxidase, erosterol biosynthesis |
Dictyostelium discoideum | DDB_G0293584 | squalene epoxidase |
Homo sapiens | ENSG00000104549 | squalene epoxidase |
Leishmania braziliensis | LbrM.13.1480 | squalene monooxygenase-like protein |
Leishmania donovani | LdBPK_131360.1 | squalene monooxygenase-like protein |
Leishmania infantum | LinJ.13.1360 | squalene monooxygenase-like protein |
Leishmania major | LmjF.13.1620 | squalene monooxygenase-like protein |
Leishmania mexicana | LmxM.13.1620 | squalene monooxygenase-like protein |
Mus musculus | ENSMUSG00000022351 | squalene epoxidase |
Oryza sativa | 4332152 | Os03g0231700 |
Oryza sativa | 4332153 | Os03g0231800 |
Saccharomyces cerevisiae | YGR175C | squalene monooxygenase |
Trypanosoma brucei gambiense | Tbg972.11.3640 | squalene monooxygenase, putative |
Trypanosoma brucei | Tb927.11.3270 | squalene monooxygenase, putative |
Trypanosoma congolense | TcIL3000_0_58900 | squalene monooxygenase, putative |
Trypanosoma cruzi | TcCLB.509589.20 | squalene monooxygenase, putative |
Trypanosoma cruzi | TcCLB.503999.10 | squalene monooxygenase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.02.0780 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.02.0780 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.02.0780 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb11.02.0780 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
YGR175C | Saccharomyces cerevisiae | inviable | yeastgenome |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Homo sapiens | squalene epoxidase | Compounds | References |
Rattus norvegicus | Squalene monooxygenase | Compounds | References |
Sus scrofa | Squalene epoxidase | Compounds | References |